AdvancePCS Adds Specialty Disease Management With Accordant Acquisition
Executive Summary
AdvancePCS' acquisition of Accordant expands the pharmacy benefit management company's interest in specialty drug products into the area of disease management
You may also be interested in...
FTC Review Of Caremark Deal Will Be Fourth Look At PCS
FTC's review of the Caremark/AdvancePCS merger will be the agency's fourth look at the PCS pharmacy benefit management business in less than a decade - but the first time the agency has considered a straightforward horizontal merger among independent, stand-alone PBMs
FTC Review Of Caremark Deal Will Be Fourth Look At PCS
FTC's review of the Caremark/AdvancePCS merger will be the agency's fourth look at the PCS pharmacy benefit management business in less than a decade - but the first time the agency has considered a straightforward horizontal merger among independent, stand-alone PBMs
Medicare Disease Management Should Focus On Part B Drugs – AdvancePCS
AdvancePCS is recommending that Medicare disease management initiatives begin with programs that would address Part B-covered drug